Home » Topics » BioWorld Science

BioWorld Science
RSS

Cellect signs stem cell collaboration agreement with Cell2in

Aug. 14, 2018

PIM-2 kinase suppresses T-cell responses to alloantigen and tumor cells

Aug. 14, 2018

Kidney cancer grows up, too

Aug. 14, 2018

Tightening pores fights prostate cancer

Aug. 14, 2018

Discovery of a novel enzymatic function of histone deacetylase 11

Aug. 14, 2018

Biomarkers to identify candidates for CAR T-cell immunotherapy

Aug. 14, 2018

Development of riluzole prodrugs for the treatment of amyotrophic lateral sclerosis

Aug. 14, 2018

Discovery of the oncological action of the long non-coding RNA, THOR, in renal cell carcinoma

Aug. 14, 2018

Phase I safety data reported for cannabinoid therapy in drug-resistant pediatric epilepsy

Aug. 14, 2018

Iterum Therapeutics initiates phase III testing of sulopenem etzadroxil

Aug. 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...